Fosun Pharma Sells 6% Stake in Gland Pharma via Open Market
Gland Pharma Ltd 路 Acquisition/ Disposal of Shares 路 01 Oct 2026, 2:26 pm
Fosun Pharma Sells 6% Stake in Gland Pharma via Open Market Promoter Fosun Pharma Industrial Pte. Ltd. sold 98,97,000 equity shares, representing a 6.00% stake (5.95% on a diluted basis) in Gland Pharma Limited via open market transactions on 4th Sep'26. Following the disposal, Fosun Pharma's shareholding in Gland Pharma declined from 8,53,93,894 shares (51.76% of total voting capital; 51.36% diluted) to 7,54,96,894 shares (45.76% of total voting capital; 45.41% diluted).
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
